Illuminating Immunohistochemistry: From Biomarker To Clinical Trial Assay

This on-demand session offers a comprehensive introduction to Immunohistochemistry (IHC), beginning with its applications in preclinical research and extending to its critical role in early clinical trials. Amanda Woodrooffe, PhD and Dawn Butler, MD, guide you through the fundamental aspects of IHC. They will highlight its significance in biomarker validation and the transition from preclinical assay development to early clinical application.

The webinar delves into the antibody selection for both commercial and proprietary types in detail. Viewers will gain an understanding of the advantages of using IHC for target and biomarker validation, and explore its diverse applications in disease screening and treatment decision-making. This session is designed to equip you with the knowledge needed to effectively utilize IHC in your research and clinical practice.